Skip to content
  • Sunday, 26 July 2026
  • 2:59 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Apr 11, 2026 0

This groundbreaking research from the Johns Hopkins Kimmel Cancer Center marks a significant stride in the quest for more effective…

Read More
Clinical Diagnostics & Pathology

Johns Hopkins Researchers Unveil Groundbreaking Epigenetic Instability Index to Revolutionize Early Cancer Detection Through Advanced Liquid Biopsy

Reynand Amr Wu Apr 4, 2026 0

A pioneering development from researchers at the Johns Hopkins Kimmel Cancer Center is set to significantly enhance the accuracy and…

Read More
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Mar 27, 2026 0

This groundbreaking research from the Johns Hopkins Kimmel Cancer Center heralds a new era in early cancer detection, introducing a…

Read More
Clinical Diagnostics & Pathology

Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy

Reynand Amr Wu Mar 20, 2026 0

Researchers at Johns Hopkins Kimmel Cancer Center have introduced a groundbreaking advancement in liquid biopsy technology, demonstrating that measuring the…

Read More
TWiV 1284: Clinical Update with Dr. Daniel GriffinWashington University Researchers Develop Single Injection Cellular Immunotherapy to Target Alzheimer’s Disease Amyloid PlaquesFish oil may be hurting your brain, new study findsBuilding Declarative Data Pipelines with Snowflake Dynamic Tables: A Workshop Deep Dive
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ